Find trials
Search tips

A Study to Compare SeLux Rapid Blood Culture Method with Standard-of-Care

Overview

About this study

The purpose of this study is to evaluate the positivity rate of the Selux rapid blood culture platform compared with the  standard clinical platform using blood samples drawn from adult patients with suspected septicemia or bacteremia. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Age ≥ 18 years old.
  • Suspected of having bacteremia or septicemia.

Exclusion Criteria: 

  • Age < 18 years old.
  • Pregnancy.
  • Inability to provide consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Casey Clements, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20508805

Mayo Clinic Footer